ABOUT US

Innocan Pharma™ is a specialty pharmaceutical company, developing products that harness the unique properties of Cannabinoids combined with smart delivery formulations.

a highly experienced management team 

with a proven track record
in the pharmaceutical industry.

INNOCAN pharmacannabinoid integrated formulas

Cannabinoids interact with the endocannabinoid receptor system, which is located throughout the body and plays an important role in many processes. Aims to harness  cannabinoids to target a wide variety of health conditions. Innocan Pharma™ plans to initially innovate new dermatology treatments.

Endocannabinoid receptor system
Located throughout the body

Topical effect

INNOCAN Pharma™ COMPANY OVERVIEW

BREAKTHROUGH INNOVATION

Cannabinoid-integrated enhanced formula with smart dermatology platform

 

OUTSTANDING PRODUCTS

Patent-pending formulas

 

Quality of life

Improved efficacy, administration and compliance

OUR FOCUS FOR RAPID GROWTH

BRANDED
CBD-INTEGRATED pharmaceuticals

  • Relief of Psoriasis symptoms (topical treatments)
  • Muscle Pain and Rheumatic Pain (topical treatment)

INJECTABLE
CONTROLLED-RELEASE
CBD TREATMENTS

  • Collaboration with Yissum Research Development, a commercial research arm of Hebrew University of Jerusalem
  • Breakthrough platform for delivery of cannabinoids by controlled injection to specific internal body target.

OUT-SOURCING
R&D EXPERTISE for
CBD-integrated
non-pharmaceuticaLS

  • Best-in-class R&D/licensing team
  • Experts in developing integrated products for various dermal applications

OUR FIRST-LINE PRODUCTS

A new hope in PSORIASIS treatment

Psoriasis is a terrible auto-immune chronic skin disorder, affecting more than 125 million people worldwide –over 60% of psoriasis patients suffer from clinical depression! We at Innocan Pharma™ want to change this.

Innovative Formula: Psoriasis Cream with Cannabinoid complex & Smart Delivery System

Synergistic effect of Salicylic Acid and CBD Hemp Oil (Cannabinoid complex)

Release on demand for an “On-the-go” solution
Relief from Psoriasis: Itching, Irritation, Redness, Scaling, Inflammation

Safe, effective and easy to use

Free from coal tar and steroids

Nourish and Moisturize

Relief from minor arthritis pain, backaches or muscle and joint pain

Cannabinoid absorbs quickly on the skin

Safe & easy-to-use

INNOVATIVE, FAST-ACTING PAIN RELIEF CREAM

1.5 billion people worldwide are affected by pain, with 50% of doctors’ visits pain related!

We at Innocan Pharma™ want to help the millions of patients seeking better topical treatment options 

Patent-pending, enhanced amart formula 

Effect of Menthol & Methyl salicylate with CBD Hemp oil (Cannabinoid complex)

Release on demand for an “On-the-go” solution

MULTI DISCIPLINARY MANAGEMENT TEAM WITH

Management Team

Ron Mayron

 Founder & Executive Chairman

Extensive experience in the pharmaceutical sector. Served as Teva CEO Israel & Africa, previously CEO of SLE and CEO Abic Pharma. He currently serves as Director & Chairman of a variety of public and private companies.

Yoram Drucker

Founder VP BD

 

Successful Israeli entrepreneur and expert in the establishment of start-ups. Co-founded Pluristem (NASDAQ:PSTI), Brainstorm (NASDAQ:BCLI) and Cell Source Ltd. (CLCS.OB).

Iris Bincovich

Founder & CEO

Vast experience and proven track record in developing global business strategies to open and penetrate new markets. Managed hundreds of successful international transactions from senior management positions (Kamedis, Efal). Accompanied startups from early stage to commercialization (Tagra). 

Moshe Haukalio

CFO

Vast CFO experience for public and private companies. Served as the CFO of Pfizer Israel, Merck. Extensive experience in Biotech.
Accompanied fast-growing companies from early stage to the highly regulated arena of public companies.

Nir Avram

Founder & CTO

Senior pharmaceutics scientist with more than 30 years of experience. Serves as VP R&D at Careline, a member of the pharmaceutical innovation team at Perrigo. He holds several patents in OTC (over-the-counter) applications.

HIGHLY EXPERIENCED Advisory Board

PROFESSOR CHEZY BARENHOLZ

Scientific Advisor

Professor of Biochemistry and Head of the Department of Biochemistry at the Hebrew University of Jerusalem. He is on the Editorial Boards of Chemistry and Physics of Lipids and the Journal of Liposome Research. He is one of the key inventors of DOXIL, marketed by Johnson & Johnson as a cancer treatment. He has authored over 300 publications and holds over 30 patents.

Michael

Professor Michael David

Scientific Advisor

Internationally recognized dermatologist and award-winning scientistHead of the Dermatology Department, Rabin Medical Center, Israel. Authored and co-authored over 200 national and international publications. Worked as a reviewer for reputed professional journals

2_advisor_stephan

Dr. Stephen Cherkez

IP Strategy

Served as head of Teva’s Chemical Research Division; founder of Chem-Agis and President of its chemistry division; and VP BD at Agis. Since 2003, he has held a double position at Perrigo as VP Intellectual Property and VP Product Development. He has filed and participated in the writing of 33 patent families.

News

InnoCan Enhancing OTC Drugs for Psoriasis and Pain with Cannabis

Read More >

TechNation: Cannabis-based Drugs Startup InnoCan Raises $830,000 via Crowdfunding Reported in Haaretz

Read More >

First Successful Internet Capital Raising in Israel: InnoCan is Featured in the Marker (Hebrew)

Read More >

InnoCan Launches Equity Fundraising Campaign with PipelBiz

Read More >

InnoCan Recruits 500 Investors Online to Raise NIS 3 Million as Highlighted in Globes

Read More >

InnoCan Featured in the Globes (English)

Read More >

Reshet.tv Talks About InnoCan

Read More >

InnoCan Featured on the Financial News Channel, Bizportal

Read More

InnoCan Published in the Globes (Hebrew)

Read More >

InnoCan TV Interview on Arutz Sheva

Read More >

CONTACT US

Yoram Drucker
YoramD@InnocanPharma.com
+972.54.471.1171

Iris Bincovich
IrisB@InnocanPharma.com
+972.54.301.2842